Dronabinol FDA approval date

The FDA approved Dronabinol (Phase 3 Comparator - Reference Listed Drug/Dronabinol) on 31 May 1985.

FDA approval date
31 May 1985

Drug identity checked against registry records

Also recorded as Phase 3 Comparator - Reference Listed Drug/Dronabinol

Included trials

TrialSponsorPhaseStatusPrimary completion
RePOSA-Revealing the Efficacy of IHL-42X Use in Patients With OSANCT06146101Incannex Healthcare LtdPhase 2, Phase 3Completed2025-05-20Actual

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
1985-05-31DayDronabinolFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA018651", "applicant_as_listed_by_fda": "ALKEM LABS LTD", "brand_names": ["MARINOL"], "active_ingredients": ["DRONABINOL"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19850531", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026